Immunomedics Receives Thomas Alva Edison Patent Award From Research & Development Council of New Jersey
Immunomedics Receives Thomas Alva Edison Patent Award From Research & Development Council of New Jersey
MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other …